ACCL1931
OPEN TO ACCRUAL
Ph3 Levocarnitine Prophylaxis for AYA in ALL Therapy
MM1OAEA02
OPEN TO ACCRUAL
Ph II Study of Venetoclax+HMA-Based Therapies for Txt of Older+Unfit Adults w/ND FLT3-AML
MYELOMATCH
OPEN TO ACCRUAL
Master Screening Protocol for Tier Advancement in the NCI myeloMATCH Trials
UW19086
OPEN TO ACCRUAL
LTFU Protocol for Subjects Treated with Gene-Modified T Cells
UW23093
OPEN TO ACCRUAL
Ph 1 Study of Venetoclax/Aza or Venetoclax in Combo w/ Ko-539 or 7+3 in combo w/Ko-539 in AML
UW23129
OPEN TO ACCRUAL
Ph1 Dose-Escalation Trial of Mesenchymal Stromal Cells in pts w Medical Xerostomia
UW24046
OPEN TO ACCRUAL
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-ALL
UW24056
OPEN TO ACCRUAL
PH1/1b Study of CLK Inhibitor BH-30236 in Adutls with R/R AML or HR-MDS